Essential role of NF-κB and AP-1 transcription factors in TNF-α-induced TSLP expression in human airway smooth muscle cells

被引:82
作者
Redhu, Naresh Singh [1 ]
Saleh, Ali [1 ]
Halayko, Andrew J. [2 ]
Ali, Aliyah S. [1 ]
Gounni, Abdelilah S. [1 ]
机构
[1] Univ Manitoba, Dept Immunol, Fac Med, Winnipeg, MB R3E 0T5, Canada
[2] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 0T5, Canada
基金
加拿大健康研究院;
关键词
airway inflammation; allergic asthma; peptide inhibitors; cytokine; gene regulation; activator protein-1; THYMIC STROMAL LYMPHOPOIETIN; HUMAN EPITHELIAL-CELLS; GENE-EXPRESSION; P38; MAPK; INFLAMMATION; PATHWAY; INHIBITION; ASTHMA; INTERLEUKIN-6; PATHOGENESIS;
D O I
10.1152/ajplung.00301.2009
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Redhu NS, Saleh A, Halayko AJ, Ali AS, Gounni AS. Essential role of NF-kappa B and AP-1 transcription factors in TNF-alpha-induced TSLP expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 300: L479-L485, 2011. First published December 10, 2010; doi:10.1152/ajplung.00301.2009.-Human airway smooth muscle (HASM) cells are a rich source of inflammatory mediators that may propagate the airway inflammatory responses. Recent studies from our laboratory and others demonstrate that HASM cells express the proallergic cytokine thymic stromal lymphopoietin (TSLP) in vitro and in vivo. Compelling evidence from in vitro studies and animal models suggest that the TSLP is a critical factor sufficient and necessary to induce or maintain the allergic airway inflammation. Despite of an immense interest in pathophysiology of TSLP in allergic inflammation, the triggers and mechanisms of TSLP expression remain inadequately understood. In this study, we found that TNF-alpha upregulates the TSLP mRNA and induces high levels of TSLP protein release in primary human ASM cells. Interestingly, TNF-alpha induced the TSLP promoter activity (P < 0.05; n = 4) in HASM that was mediated by upstream NF-kappa B and activator protein-1 (AP-1) binding sites. Mutation in NF-kappa B and AP-1 binding sites completely abrogated the effect of TNF-alpha-mediated TSLP promoter activity and so did the expression of a dominant-negative mutant construct of I kappa B kinase. Furthermore, the peptide inhibitors of I kappa B kinase or NF-kappa B inhibited the TNF-alpha-induced TSLP protein release (P < 0.05; n = 3) in HASM. Collectively, our data suggest a novel important biological role for NF-kappa B pathway in TNF-alpha-induced TSLP expression in HASM and recommend this as a prime target for anti-inflammatory drugs.
引用
收藏
页码:L479 / L485
页数:7
相关论文
共 43 条
[1]
A role for TSLP in the development of inflammation in an asthma model [J].
Al-Shami, A ;
Spolski, R ;
Kelly, J ;
Keane-Myers, A ;
Leonard, WJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) :829-839
[2]
Thymic stfomal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells [J].
Allakhverdi, Zoulfia ;
Comeau, Michael R. ;
Jessup, Heidi K. ;
Yoon, Bo-Rin Park ;
Brewer, Avery ;
Chartier, Suzanne ;
Paquette, Nicole ;
Ziegler, Steven F. ;
Sarfati, Marika ;
Delespesse, Guy .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) :253-258
[3]
Thymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cells [J].
Allakhverdi, Zoulfia ;
Comeau, Michael R. ;
Jessup, Heidi K. ;
Delespesse, Guy .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (04) :958-960
[4]
Activation of tumor necrosis factor receptor 1 in airway smooth muscle: A potential pathway that modulates bronchial hyper-responsiveness in asthma? [J].
Amrani Y. ;
Chen H. ;
Panettieri Jr. R.A. .
Respiratory Research, 2000, 1 (1) :49-53
[5]
Amrani Y, 2001, MOL PHARMACOL, V60, P646
[6]
Activation of p55 tumor necrosis factor-α receptor-1 coupled to tumor necrosis factor receptor-associated factor 2 stimulates intercellular adhesion molecule-1 expression by modulating a thapsigargin-sensitive pathway in human tracheal smooth muscle cells [J].
Amrani, Y ;
Lazaar, AL ;
Hoffman, R ;
Amin, K ;
Ousmer, S ;
Panettieri, RA .
MOLECULAR PHARMACOLOGY, 2000, 58 (01) :237-245
[7]
Iκ-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma [J].
Birrell, MA ;
Hardaker, E ;
Wong, S ;
McCluskie, K ;
Catley, M ;
De Alba, J ;
Newton, R ;
Haj-Yahia, S ;
Pun, KT ;
Watts, CJ ;
Shaw, RJ ;
Savage, TJ ;
Belvisi, MG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) :962-971
[8]
Validation of the anti-inflammatory properties of small molecule IκB kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle [J].
Catley, Matthew C. ;
Sukkar, Maria B. ;
Chung, K. Fan ;
Jaffee, Bruce ;
Liao, Sha-Mei ;
Coyle, Anthony J. ;
Haddad, El-Bdaoui ;
Barnes, Peter J. ;
Newton, Robert .
MOLECULAR PHARMACOLOGY, 2006, 70 (02) :697-705
[9]
Transcriptional regulation of cytokine function in airway smooth muscle cells [J].
Clarke, Deborah ;
Damera, Gautam ;
Sukkar, Maria B. ;
Tliba, Omar .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2009, 22 (05) :436-445
[10]
PKCβII augments NF-κB-dependent transcription at the CCL11 promoter via p300/CBP-associated factor recruitment and histone H4 acetylation [J].
Clarke, Deborah L. ;
Sutcliffe, Amy ;
Deacon, Karl ;
Bradbury, Dawn ;
Corbett, Lisa ;
Knox, Alan J. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (05) :3503-3514